News Conference News TCT 2025 DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES Yael L. Maxwell November 04, 2025
News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025
Presentation TCT 2025 TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy Presenter: Mehmet Cilingiroglu October 27, 2025
Presentation TCT 2025 TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial Presenter: Devi G. Nair October 27, 2025
Presentation TCT 2025 Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study Presenter: Grant William Reed October 25, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News TCT 2024 After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry Yael L. Maxwell November 05, 2024
Presentation TCT 2024 TCT 956: Validation of the VARC-HBR Criteria in TAVI Patients on Oral Anticoagulation Presenter: Daniel Overduin October 30, 2024
Presentation TCT 2024 TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life Presenter: Dirk Jan van Ginkel October 29, 2024
News Conference News TCT 2024 LAAO Outcomes Similar Regardless of Operator’s Specialty Todd Neale October 27, 2024
Presentation TCT 2024 TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis Presenter: Wilbert Bor October 27, 2024
Presentation TCT 2023 Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials Presenter: Yousif Ahmad October 25, 2023
Presentation TCT 2023 TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography Presenter: Ting-Yu Wang October 25, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
Presentation TCT 2022 TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation Presenter: Norman Mangner September 19, 2022
Presentation TCT 2022 TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation Presenter: Claudio Cigalini September 18, 2022
News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
News Conference News TCT 2022 As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant Michael O'Riordan September 18, 2022
News Conference News TCT 2022 FLASH: More Data to Support Mechanical Thrombectomy in PE L.A. McKeown September 18, 2022
News Conference News TCT 2022 Dedicated Catheter for Acute PE Shows Promise in IDE Trial L.A. McKeown September 17, 2022